3
Registered trials
0
Recruiting
3
Unique sponsors
3
Unique IMPs
2
Commercial trials
Drug classes (ATC)
—
ATC code not specified
2
R
Respiratory (ATC R)
2
Mechanism of action (INN-stem analysis)
Unknown / small molecule
3 substances
Phase II:
1
Phase IV:
2
Phase I (First in Human):
1
Phase II
1 trial-
PendingRycarma Therapeutics Inc. CommercialSURLORIAN
Phase IV
2 trials-
EndedVaestra Goetalandsregionen AcademicSALBUTAMOL
-
EndedVaestra Goetalandsregionen AcademicSALBUTAMOL
Phase I (First in Human)
1 trial-
PendingAstellas Gene Therapies Inc. CommercialASP2957
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Vaestra Goetalandsregionen | Academic | 2 | Phase IV | 0 |
| Rycarma Therapeutics Inc. | Commercial | 1 | Phase II | 0 |
| Astellas Gene Therapies Inc. | Commercial | 1 | Phase I (First in Human) | 0 |
New trials by year
2021
2